Inflammation in Neurogenerative Diseases: Mechanisms and Therapeutic Frontiers
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (30 June 2026) | Viewed by 5036
Editor
Interests: neurodegenerative diseases; inflammation; eye diseases; gene therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic inflammation plays a critical role in the development and progression of many neurodegenerative diseases, including Alzheimer’s, Parkinson’s, multiple sclerosis, and age-related macular degeneration. Increasing evidence points to the complex involvement of immune responses, both in the brain and from the periphery, including the actions of microglia, astrocytes, and other immune cells, in driving neuronal damage and loss.
This Special Issue, entitled "Inflammation in Neurogenerative Diseases: Mechanisms and Therapeutic Frontiers", invites contributions that explore how inflammation shapes the course of neurodegenerative diseases and what we can do to intervene. We are particularly interested in studies that uncover new mechanisms of neuroinflammation, identify promising biomarkers, and propose innovative therapies—ranging from gene therapy and immunomodulation to nanomedicine.
Dr. Shao-Bin Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroinflammation
- neurodegenerative diseases
- biomarkers mitochondria dysfunction
- microglia
- immune response
- therapeutic development
- gene therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
